Skip to content

TECIL Chemicals and Hydro Power Limited (TECILCHEM)

Small Cap

Power stocks · Small cap · NSE

TECIL Chemicals and Hydro Power Limited operates in Chemicals, within the Power sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹9.39
-0.50 · -5.06%
Market cap ₹18 Cr
Data qualityVerify one data layerQuote updated 19 Oct, 05:50 pm IST
Details
Quote19 Oct, 05:50 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result16 Aug, 01:25 am IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage7/14 · 50%
Valuation2026-07-20 · Rf 6.8% · Power P/E 16.8 (n=92)
Technical timing lens

Trend score and candlestick chart

41Neutral

MACD + · near 52W low

Stock trend: 41
Sector RS: —
Power FPI tailwindNot confirmed

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

TECILCHEMD candles · FIT view-30.0%
Latest close ₹9.39 on 2026-10-19
Bar
-5.4%
RSI
49
MACD hist
0.03
52W pos
10%
Visible chart range
Candle interval
2026-10-19O ₹9.93H ₹9.93L ₹9.20C ₹9.39Vol 1,694 sh
₹7.66₹9.55₹11.45₹13.35₹15.2552L₹9.392026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

TECILCHEMNifty PowerNifty 500
-17%-9%-1%+6%20 Jul1 Sept19 Oct19 Oct 2026TECILCHEM -4.4%Nifty Power -13.0%Nifty 500 -5.6%
TECILCHEM
-4.4%
Nifty 500
-5.6%
Nifty Power
-13.0%
Vs Nifty 500
+1.2 pp
Chart stats
19 Oct 2026
From 52W high
-57.5%
₹22.1
52W range position
10%
₹8 - ₹22.1
ATR (14)
8.0%
₹0.7
Volume vs 20D
0.10x
Latest completed session
Avg traded value
₹0 Cr
20-session average
20D price channel
₹8.6 - ₹10.3
48.9% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.

Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · OVERVALUED
1

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Pending data
—

Revenue NDF · PAT NDF YoY

Technical
Neutral
41

Price trend and sector-relative-strength timing.

Valuation
Legacy model
—

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
59

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Pending data

YoY comparison unavailable - result verdict pending data

Filed 30 Jun 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹0 CrNDFNDF
EBITDA₹-0.5 Cr-557.1%-206.7%
Operating marginNDFNDFNDF
PAT₹-0.2 CrNDFNDF
PAT marginNDFNDFNDF

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
—
P/B
—
EV/EBITDA
—
Market Cap
18.00Cr

Profitability

ROE
—
ROCE
—
ROA
-4.36%
Dividend Y
—

Growth (CAGR)

Revenue 5Y
—
EPS 5Y
—
Revenue 3Y
-19.00%
EPS 3Y
-19.00%

Balance Sheet

Debt/Equity
0.00
Interest Coverage
—
Altman Z
-1.06
Book Value
—

Cash Flow

FCF Yield
—
FCF Positive Y
0/5
OCF
-0.28 Cr
EPS TTM
—

Shareholding

Promoter Hold
47.71%
Promoter Pledge
0.00%
Momentum 52W
14%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 0.0
0Mar 2017: 0.0Mar 2018: 0.0Mar 2019: 0.0Mar 2020: 0.0Mar 2021: 0.0Mar 2022: 0.0Mar 2023: 0.0Mar 2024: 0.0Mar 2025: 0.0Mar 2026: 0.0FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Net Profit

₹ Cr
Latest: -0.4-7.7% vs prev
-4.40Mar 2017: -2.4Mar 2018: -1.2Mar 2019: -0.5Mar 2020: -0.5Mar 2021: -4.4Mar 2022: -0.4Mar 2023: -1.4Mar 2024: -0.4Mar 2025: -0.4Mar 2026: -0.4FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Return on Equity

%
No data

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Bearish setup

Trend is weak — long-term trend down. RSI 49.

  • Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
  • SMA20 roughly flat — short-term momentum stalled.
  • RSI(14) at 49 — falling, no extreme reading.
  • MACD above signal but histogram contracting — bullish momentum cooling.
  • 57% off 52W high · 17% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

8
RS percentile
Stage 4 Downtrend
1M return
-3.9%
3M return
-4.4%
6M return
-33.3%
1Y return
-53.2%
RS 1D
-4
RS 20D
+1
Sector rank
#11
Industry rank
-
Stage evidence
  • Price is 12.6% below the 30-week proxy.
  • The 50-DMA is below the 30-week proxy and its slope is falling -4.2%.
  • Both 3-month and 6-month returns are negative.
50-DMA
price above
200-DMA
price below
Sector
neutral
Industry
unranked
Relative-strength line vs Nifty 500 (base 100)
258 observations
19 Oct 2026Value 50.01-4.07%
39567491109Sept 25Feb 26Jun 26Oct 2650
RS vs Nifty 50050

Valuation & peers

U-Score 1 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

1U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation2/30
Growth0/25
Quality0/20
Balance Sheet6/15
Cash Flow0/10
Piotroski
2/9 (+0)
Penalties
-7
Raw sum
1

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

1/100 · legacy band OVERVALUED

Positive drivers

  • Balance sheet contributes 6/15 to the score.
  • Valuation contributes 2/30 to the score.
  • Growth contributes 0/25 to the score.

Main drags

  • Altman Z is -1.1, in distress territory.
  • Penalty bucket subtracts 7 points.
  • Growth is weaker at 0/25; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
—
PB
—
EV/EBITDA
—
ROE
—
ROCE
—
FCF Yield
—
Debt/Equity
0.0
MoS
—
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
1
Previous: 1
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
—
No stored baseline yet

Score history

12 stored score snapshots. Latest stored move: +0 points.

21 Oct 2026
v4.3-runtime-valuation
1
1
1
1
1
1
1
1
1
1
1
1

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
—
Growth-justified P/E
2.5
Growth-justified Value
—
— MoS
PEG
—

Comparable companies

Peers

Business-comparable peers in Power — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
YCCL
SME
Yasons Chemex Care Ltd.
Specialty Chemicals
match 99
22
17.5
2.3%
-839%
OVERVALUED
VSCL
SME
VADIVARHE SPECIALITY CHEMICALS LTD.
Specialty Chemicals
match 94
18
—
—
—
OVERVALUED
RITEZONE
SME
Rite Zone Chemcon India Ltd.
Specialty Chemicals
match 92
53
21.2
2.2%
+43%
FAIR VALUE
MCON
SME
Mcon Rasayan India Ltd.
Specialty Chemicals
match 91
60
9.8
8.8%
+75%
UNDERVALUED
DCW
Small
DCW Limited
Specialty Chemicals
match 89
15
—
-0.7%
—
OVERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

TECIL Chemicals and Hydro Power Limited operates in Chemicals, within the Power sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
59Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 25th percentile of the scored universe and 30th percentile within Power. Main check: cash conversion is weak at 28/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
3 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
25th percentile

overall median 67 · Power: 30th pctile, median 65 · Small: 28th pctile, median 66

Evidence depth
Financial-only

3 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
28
weak · profit to cash conversion
Balance sheet
80
strong · leverage and solvency
Discipline
60
acceptable · capital discipline
Results
55
watch · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸Debt/equity is 0.00.

Trust risks

  • ▸Operating cash flow is negative at ₹0 Cr.
  • ▸Only 0 years of positive FCF.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

6 shown
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 2 Sep - Intimation regarding copy of newspaper advertisements published - Notice of 81st Annual General Meeting of the Company

Source: Bse

Open source ↗
Annual report

Reg. 34 (1) Annual Report. 1 Sep

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 28 May - Copy of News Paper Publication Under Regulation 47 of SEBI(LODR)Regulations, 2015 regarding the Audited Financial Results for the Quarter and Year ended 31.03.2026

Source: Bse

Open source ↗
Announcement

Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31.03.2026 27 May - Board approved audited standalone results for FY2026; net loss ₹2.47 lakh, auditors gave unmodified opinion.

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.